177 related articles for article (PubMed ID: 29625556)
1. Targeted next generation sequencing with an extended gene panel does not impact variant detection in mitochondrial diseases.
Plutino M; Chaussenot A; Rouzier C; Ait-El-Mkadem S; Fragaki K; Paquis-Flucklinger V; Bannwarth S
BMC Med Genet; 2018 Apr; 19(1):57. PubMed ID: 29625556
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
[TBL] [Abstract][Full Text] [Related]
3. New genes and pathomechanisms in mitochondrial disorders unraveled by NGS technologies.
Legati A; Reyes A; Nasca A; Invernizzi F; Lamantea E; Tiranti V; Garavaglia B; Lamperti C; Ardissone A; Moroni I; Robinson A; Ghezzi D; Zeviani M
Biochim Biophys Acta; 2016 Aug; 1857(8):1326-1335. PubMed ID: 26968897
[TBL] [Abstract][Full Text] [Related]
4. Targeted next generation sequencing identifies novel pathogenic variants and provides molecular diagnoses in a cohort of pediatric and adult patients with unexplained mitochondrial dysfunction.
Nogueira C; Silva L; Pereira C; Vieira L; Leão Teles E; Rodrigues E; Campos T; Janeiro P; Gaspar A; Dupont J; Bandeira A; Martins E; Magalhães M; Sequeira S; Vieira JP; Santos H; Vilarinho S; Vilarinho L
Mitochondrion; 2019 Jul; 47():309-317. PubMed ID: 30831263
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing.
Calvo SE; Compton AG; Hershman SG; Lim SC; Lieber DS; Tucker EJ; Laskowski A; Garone C; Liu S; Jaffe DB; Christodoulou J; Fletcher JM; Bruno DL; Goldblatt J; Dimauro S; Thorburn DR; Mootha VK
Sci Transl Med; 2012 Jan; 4(118):118ra10. PubMed ID: 22277967
[TBL] [Abstract][Full Text] [Related]
6. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum.
Kose M; Isik E; Aykut A; Durmaz A; Kose E; Ersoy M; Diniz G; Adebali O; Ünalp A; Yilmaz Ü; Karaoğlu P; Edizer S; Tekin HG; Özdemir TR; Atik T; Onay H; Özkınay F
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):417-430. PubMed ID: 33629572
[TBL] [Abstract][Full Text] [Related]
7. Targeted exome sequencing of suspected mitochondrial disorders.
Lieber DS; Calvo SE; Shanahan K; Slate NG; Liu S; Hershman SG; Gold NB; Chapman BA; Thorburn DR; Berry GT; Schmahmann JD; Borowsky ML; Mueller DM; Sims KB; Mootha VK
Neurology; 2013 May; 80(19):1762-70. PubMed ID: 23596069
[TBL] [Abstract][Full Text] [Related]
8. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain.
Gonzalez-Quereda L; Rodriguez MJ; Diaz-Manera J; Alonso-Perez J; Gallardo E; Nascimento A; Ortez C; Natera-de Benito D; Olive M; Gonzalez-Mera L; Munain AL; Zulaica M; Poza JJ; Jerico I; Torne L; Riera P; Milisenda J; Sanchez A; Garrabou G; Llano I; Madruga-Garrido M; Gallano P
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403337
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation.
Bacquet J; Stojkovic T; Boyer A; Martini N; Audic F; Chabrol B; Salort-Campana E; Delmont E; Desvignes JP; Verschueren A; Attarian S; Chaussenot A; Delague V; Levy N; Bonello-Palot N
BMJ Open; 2018 Oct; 8(10):e021632. PubMed ID: 30373780
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing of suspected mitochondrial patients in clinical practice.
Wortmann SB; Koolen DA; Smeitink JA; van den Heuvel L; Rodenburg RJ
J Inherit Metab Dis; 2015 May; 38(3):437-43. PubMed ID: 25735936
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum.
Vasta V; Merritt JL; Saneto RP; Hahn SH
Pediatr Int; 2012 Oct; 54(5):585-601. PubMed ID: 22494076
[TBL] [Abstract][Full Text] [Related]
13. MITO-FIND: A study in 390 patients to determine a diagnostic strategy for mitochondrial disease.
Kerr M; Hume S; Omar F; Koo D; Barnes H; Khan M; Aman S; Wei XC; Alfuhaid H; McDonald R; McDonald L; Newell C; Sparkes R; Hittel D; Khan A
Mol Genet Metab; 2020; 131(1-2):66-82. PubMed ID: 32980267
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome.
Dinwiddie DL; Smith LD; Miller NA; Atherton AM; Farrow EG; Strenk ME; Soden SE; Saunders CJ; Kingsmore SF
Genomics; 2013 Sep; 102(3):148-56. PubMed ID: 23631824
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing for mitochondrial disorders.
Carroll CJ; Brilhante V; Suomalainen A
Br J Pharmacol; 2014 Apr; 171(8):1837-53. PubMed ID: 24138576
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
17. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
18. Validation and clinical performance of a combined nuclear-mitochondrial next-generation sequencing and copy number variant analysis panel in a Canadian population.
Levy MA; Kerkhof J; Belmonte FR; Kaufman BA; Bhai P; Brady L; Bursztyn LLCD; Tarnopolsky M; Rupar T; Sadikovic B
Am J Med Genet A; 2021 Feb; 185(2):486-499. PubMed ID: 33300680
[TBL] [Abstract][Full Text] [Related]
19. New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre.
Pronicka E; Piekutowska-Abramczuk D; Ciara E; Trubicka J; Rokicki D; Karkucińska-Więckowska A; Pajdowska M; Jurkiewicz E; Halat P; Kosińska J; Pollak A; Rydzanicz M; Stawinski P; Pronicki M; Krajewska-Walasek M; Płoski R
J Transl Med; 2016 Jun; 14(1):174. PubMed ID: 27290639
[TBL] [Abstract][Full Text] [Related]
20. Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing.
Dong HL; Ma Y; Li QF; Du YC; Yang L; Chen S; Wu ZY
CNS Neurosci Ther; 2019 Jan; 25(1):21-29. PubMed ID: 29756269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
